Recent Company News

• 01:28 AM ET Jul 08, 2025
  

  Deutsche Bank upgrades ARGX.BB, SOBI.SS

• 07:03 AM ET Jul 01, 2025
  

  Sobi to amend existing agreement with Apellis for ex-U.S. royalties of Aspaveli (SEK 284.00, -4.20)

• 07:03 AM ET Jul 01, 2025
  

  Apellis to receive up to $300M from royalty purchase agreement with Sobi for ex-U.S. royalties of Aspaveli (systemic pegcetacoplan) ($17.31, 0.00)

• 02:35 AM ET Jul 01, 2025
  

  Swedish Orphan Biovitrum initiated underperform at BNP Paribas Exane (SEK 288.20, 0.00)

• 05:08 PM ET Jun 30, 2025
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 08:56 AM ET Jun 30, 2025
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 07:05 PM ET Jun 27, 2025
  

  Swedish Orphan announces that FDA approved Gamifant sBLA for adults and children with HLH/MAS (SEK 284.60, 0.00)

• 02:03 AM ET Jun 20, 2025
  

  Swedish Orphan Biovitrum will be presenting wide range of clinical study updates at annual International Society on Thrombosis and Haemostasis (ISTH) Congress in Washington 21-25 June (SEK 272.60, 0.00)

• 07:18 AM ET Jun 16, 2025
  

  ADC Therapeutics announces updated ZYNLONTA data in R/R marginal zone lymphoma to be presented at ICML ($3.58, 0.00)

• 06:40 AM ET Jun 11, 2025
  

  StreetAccount Summary - European unusual volume traders